Brind.

BeOne Medicines filed reports with the SEC and was scheduled to present at a Morgan Stanley conference.

3 reports, 1 independent Updated Aug 26

Gone quiet

Reports: 3
Developments: 2
Repetition: 33%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

BeOne Medicines filed reports with the SEC and was scheduled to present at a Morgan Stanley conference.

Who's involved

What this event is mainly about

BeOne Medicines (Switzerland)Morgan Stanley

How it developed

Newest first. Tap a step to see who reported it.

Aug 26BeOne Medicines made regulatory filings and scheduled a presentation at a Morgan Stanley conference.1 source
- Business Wire
Jun 28BeOne Medicines highlighted its pipeline programs during an R&D day.

Keep exploring

The entities involved

BeOne Medicines (Switzerland)
company in Basel, Switzerland

Nothing else this week.
Morgan Stanley
U.S. investment bank
- Financial firms including Morgan Stanley, Truist Financial, Jefferies Financial Group, and CIBC issued rating and price objective updates for Clearway Energy.Mon 17:33
- Goldman Sachs, Morgan Stanley, JPMorgan Chase, and Bank of America are competing in the global investment banking sector.Mon 17:24

Coverage

Newest first; wire copies grouped

Aug 26Business WireBeOne to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference SAN CARLOS, Calif., August 26, 2025--(BUSINESS WIRE)--BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a g
Jul 16Business WireBeOne Medicines to Announce Second Quarter 2025 Financial Results on August 6 SAN CARLOS, Calif., July 16, 2025--(BUSINESS WIRE)--BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a globa
Jun 28Unknown outlet